Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem.
They leverage our inhouse developed technologies for processes such as encapsulation, spray drying, granulation, trituration, liposomal preparations and blending in an effort to drive innovation in our operations. They have established a presence in both, domestic and international markets, including key regions such as the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
According to the F&S Report, they are one of the largest producers of food-grade iron phosphate for infant nutrition, clinical nutrition, and the food and beverage sectors, in terms of production capacity with a combined annual available manufacturing capacity of 72,246 metric tons (“MT”), as of June 30, 2025. As of the same date, one of their Manufacturing Facilities has been approved by the United States Food and Drug Administration (“USFDA”) for the manufacture of mineral-based ingredients. According to the F&S Report, they are one of the largest exporters of mineral ingredients for pharmaceutical, food and nutrition industries from India to global markets in terms of volume of products exported during 2024, as of December 31, 2024.
They were the only company in India and one of nine companies globally with certification of suitability issued by the Council of Europe (“CEP”) and written confirmation certification for sale of calcium carbonate as an active pharmaceutical ingredient (“API”) in the European Union as of June 30, 2025. According to the F&S Report, they are one of the pioneers in India to introduce a product range of liposomal ingredients for nutrient absorption and stability.
Note: The actual amount will be debited when the shares are allotted to you.
Note: The actual amount will be debited when the shares are allotted to you.
An IPO offers share market participants like you and me an opportunity to be a shareholder in an erstwhile privately held company that is now going public and being listed on the market. Historically speaking, investors who choose the right IPOs make significant returns on their investments, which increases the attraction of IPOs.
Once you are a shareholder, you are eligible to receive dividends from the company proportional to the shares you own. You can also sell your stocks for profit on the stock exchange.
In exchange for its shares, the company has an opportunity to raise huge capital to be used to further enhance its business and scale up its operations. The company also has other benefits, such as credibility; visibility; better leverage to effect mergers, acquisitions and even to procure loans at lower rates of interest.
In India, the entire IPO process is ably regulated by the Securities & Exchange Board of India (SEBI), right from the IPO filing by the company to the bidding, allotments and refunds (in case you aren't allotted shares due to oversubscription).
Yes. IPO & Bonds will reflect in the portfolio.
In case the allotment is not done then bank will unblock the application money from the bank accounts upon receiving instructions from the Registrar.
Bidding time will be till 1200 hrs on the closing day of the issue.
Your bank should be a part of the ASBA participating bankers. Click here to check the list of banks.
Yes, you will receive a sms once the IPO form is processed.
BSE IPO index to track the value of companies for two years after listing subsequent to successful completion of their initial public offering (IPO).
This report provides the debit/credit entry of all the transfers done in the IPO and MF account
Click here to check the status of your IPO application
This product is a Loan Facility offered for applying in Primary Market Issues (IPOs and FPOs). With this product Investors can apply for IPOs by investing only Margin amount (specified for each IPO separately).
